Larry S McDaniel is a prominent inventor based in Ridgeland, MS (US). He has made significant contributions to the field of pneumococcal research, holding a total of 9 patents. His work focuses on the genetic and immunological aspects of pneumococcal diseases, which are critical for developing effective treatments and vaccines.

Latest Patents

Among his latest patents, McDaniel has developed innovations related to pneumococcal genes and their expression products. One notable patent is titled "Pneumococcal genes, portions thereof, expression products therefrom, and uses of such genes, portions and products." This patent includes claims related to PspAs, DNA sequences, and immunological compositions. Another significant patent is "Pneumococcal surface proteins and uses thereof," which pertains to genes encoding pneumococcal surface proteins, including the pspA and pspC genes. These inventions are crucial for advancing our understanding of pneumococcal infections and their treatment.

Career Highlights

Throughout his career, McDaniel has worked with esteemed organizations such as the UAB Research Foundation and the University of Alabama. His research has significantly impacted the field of microbiology and immunology, particularly in understanding pneumococcal diseases.

Collaborations

McDaniel has collaborated with notable colleagues, including David E Briles and Janet L Yother. These partnerships have fostered advancements in pneumococcal research and have contributed to the development of innovative solutions in the field.

Conclusion

Larry S McDaniel's contributions to pneumococcal research through his patents and collaborations highlight his role as a key innovator in the field. His work continues to influence the development of effective treatments and vaccines for pneumococcal diseases.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com